Combination pharmaceutical agents as RSV inhibitors
US-12268694-B2 · Apr 8, 2025 · US
Preparation from compounds containing heterocyclic oxygen
Preparation from compounds containing heterocyclic oxygen · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D213/14 |
| Official title | Preparation from compounds containing heterocyclic oxygen |
| Display label | Preparation from compounds containing heterocyclic oxygen |
| Total patents | 25 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly declining.
| Year | Patents |
|---|---|
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Cannabinoid derivatives as pharmaceutically active compounds and method of preparation thereof
US-2024025858-A1 · Jan 25, 2024 · US
Inhibitors of the bromodomain phd finger transcription factor (bptf) as anti-cancer agents
US-2023391730-A1 · Dec 7, 2023 · US
Oxazolidinones as TarO inhibitors
US-11738010-B2 · Aug 29, 2023 · US
Combination pharmaceutical agents as rsv inhibitors
US-2022323460-A1 · Oct 13, 2022 · US
Compound and an Organic Semiconducting Layer, an Organic Electronic Device and a Display or Lighting Device Comprising the Same
US-2022002218-A1 · Jan 6, 2022 · US
Oxazolidinones as taro inhibitors
US-2021346364-A1 · Nov 11, 2021 · US
Oxazolidinones as taro inhibitors
US-11141410-B2 · Oct 12, 2021 · US
Combination pharmaceutical agents as RSV inhibitors
US-10881666-B2 · Jan 5, 2021 · US
Oxazolidinones as taro inhibitors
US-2020261436-A1 · Aug 20, 2020 · US
Piperidine or piperazine linked imidazole and triazole derivatives and methods of use
US-10745377-B2 · Aug 18, 2020 · US
Process for the preparation of intermediate of dolutegravir
US-10442769-B2 · Oct 15, 2019 · US
Combination pharmaceutical agents as rsv inhibitors
US-2019192535-A1 · Jun 27, 2019 · US
Process for the preparation of intermediate of dolutegravir
US-2018148412-A1 · May 31, 2018 · US
Urea and amide derivatives of aminoalkylpiperazines and use thereof
US-9969743-B2 · May 15, 2018 · US
Process for the preparation of intermediate of dolutegravir
US-9963430-B2 · May 8, 2018 · US
Process for the preparation of intermediate of dolutegravir
US-2017334858-A1 · Nov 23, 2017 · US
Urea and amide derivatives of aminoalkylpiperazines and use thereof
US-2017190711-A1 · Jul 6, 2017 · US
Urea and amide derivatives of aminoalkylpiperazines and use thereof
US-9598387-B2 · Mar 21, 2017 · US
Piperidine or piperazine linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug
US-2016297792-A1 · Oct 13, 2016 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D213/14?
- CPC C07D213/14 is the Cooperative Patent Classification code for “Preparation from compounds containing heterocyclic oxygen.”
- How many patents are filed under CPC C07D213/14 (Preparation from compounds containing heterocyclic oxygen)?
- Our database includes 25 publications tagged with this CPC code.
- Is patent activity under CPC C07D213/14 growing?
- Publication counts under this code: 1 in 2024 vs 1 in 2025 (latest complete years).